http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190057131-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
filingDate 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe4f11482b34e98b57ed3b84bbe07b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb592818daacb239e96b186e7f7cdea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f053dbaa9b9bda56dd459a1855c307b
publicationDate 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20190057131-A
titleOfInvention The cyclic dinucleotide compound
abstract The present invention relates to compounds of formula I, wherein said compounds have important pharmacological properties, in particular as modulators of STING. (I) In the formula (I) R 1 , R 2 and R 3 are as defined in claim 1.
priorityDate 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016096174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016120305-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005009418-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015185565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014189805-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134397970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430256880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466980080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466508939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466513604

Total number of triples: 43.